Pan-cancer detection panel based on next-generation sequencing technology and application of detection panel

The invention belongs to the technical field of pan-cancer polygene detection and discloses a pan-cancer detection panel based on a next-generation sequencing technology. Important exon regions and partial intron regions of 141 genes are enriched by utilizing a gene probe hybridization method, so th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ZHANG QUNLING, GUO WEIJIAN, TAO ZHONGHUA, ZHANG JIAN, SHI JINXIU, PEI YUCHEN, WU XIANGHUA, HU XIN, CHANG JIANHUA, ZHANG XIAOWEI, WANG YUNJIN, HU ZHIHUANG, SHAO ZHIMIN, HUANG WEI, WANG JIALEI, HU XICHUN, LUO ZHIGUO, CAO JUNNING
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ZHANG QUNLING
GUO WEIJIAN
TAO ZHONGHUA
ZHANG JIAN
SHI JINXIU
PEI YUCHEN
WU XIANGHUA
HU XIN
CHANG JIANHUA
ZHANG XIAOWEI
WANG YUNJIN
HU ZHIHUANG
SHAO ZHIMIN
HUANG WEI
WANG JIALEI
HU XICHUN
LUO ZHIGUO
CAO JUNNING
description The invention belongs to the technical field of pan-cancer polygene detection and discloses a pan-cancer detection panel based on a next-generation sequencing technology. Important exon regions and partial intron regions of 141 genes are enriched by utilizing a gene probe hybridization method, so that accurate detection is achieved; and more importantly, a detection object is patient DNA, and ctDNA is combined with a gene panel to serve as an examination object, so that targeted detection can be realized, and the gene detection cost of a patient and the operation difficulty of an experimentercan be reduced. Meanwhile, a polygene screening list is made into a probe, and high-risk genes are detected in a targeted mode through hybridization capture sequencing, so that gene mutation with guiding significance for diagnosis and treatment can be detected more efficiently, and meanwhile certain tumor patients can be helped to participate in clinical trials. The pan-cancer detection panel hasimportant guiding signific
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN111979329A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN111979329A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN111979329A3</originalsourceid><addsrcrecordid>eNqNjbEOwjAQQ7swIOAfjg_IUDqgjKgqYkIM7NVxdUOl6BKaIMHfUwETE5Nl-dmeF_7EaoRVMFKHDMlDUIqs8HThhI4mq3hk46AY-R0n3O5QGdTR1Lhq8ME9ibUjjtEP8qFC_7u4LGY9-4TVVxfFet-c64NBDC1SZJk-clsfy7K0W1tt7K76h3kBSFBCOw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Pan-cancer detection panel based on next-generation sequencing technology and application of detection panel</title><source>esp@cenet</source><creator>ZHANG QUNLING ; GUO WEIJIAN ; TAO ZHONGHUA ; ZHANG JIAN ; SHI JINXIU ; PEI YUCHEN ; WU XIANGHUA ; HU XIN ; CHANG JIANHUA ; ZHANG XIAOWEI ; WANG YUNJIN ; HU ZHIHUANG ; SHAO ZHIMIN ; HUANG WEI ; WANG JIALEI ; HU XICHUN ; LUO ZHIGUO ; CAO JUNNING</creator><creatorcontrib>ZHANG QUNLING ; GUO WEIJIAN ; TAO ZHONGHUA ; ZHANG JIAN ; SHI JINXIU ; PEI YUCHEN ; WU XIANGHUA ; HU XIN ; CHANG JIANHUA ; ZHANG XIAOWEI ; WANG YUNJIN ; HU ZHIHUANG ; SHAO ZHIMIN ; HUANG WEI ; WANG JIALEI ; HU XICHUN ; LUO ZHIGUO ; CAO JUNNING</creatorcontrib><description>The invention belongs to the technical field of pan-cancer polygene detection and discloses a pan-cancer detection panel based on a next-generation sequencing technology. Important exon regions and partial intron regions of 141 genes are enriched by utilizing a gene probe hybridization method, so that accurate detection is achieved; and more importantly, a detection object is patient DNA, and ctDNA is combined with a gene panel to serve as an examination object, so that targeted detection can be realized, and the gene detection cost of a patient and the operation difficulty of an experimentercan be reduced. Meanwhile, a polygene screening list is made into a probe, and high-risk genes are detected in a targeted mode through hybridization capture sequencing, so that gene mutation with guiding significance for diagnosis and treatment can be detected more efficiently, and meanwhile certain tumor patients can be helped to participate in clinical trials. The pan-cancer detection panel hasimportant guiding signific</description><language>chi ; eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; ENZYMOLOGY ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20201124&amp;DB=EPODOC&amp;CC=CN&amp;NR=111979329A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76418</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20201124&amp;DB=EPODOC&amp;CC=CN&amp;NR=111979329A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZHANG QUNLING</creatorcontrib><creatorcontrib>GUO WEIJIAN</creatorcontrib><creatorcontrib>TAO ZHONGHUA</creatorcontrib><creatorcontrib>ZHANG JIAN</creatorcontrib><creatorcontrib>SHI JINXIU</creatorcontrib><creatorcontrib>PEI YUCHEN</creatorcontrib><creatorcontrib>WU XIANGHUA</creatorcontrib><creatorcontrib>HU XIN</creatorcontrib><creatorcontrib>CHANG JIANHUA</creatorcontrib><creatorcontrib>ZHANG XIAOWEI</creatorcontrib><creatorcontrib>WANG YUNJIN</creatorcontrib><creatorcontrib>HU ZHIHUANG</creatorcontrib><creatorcontrib>SHAO ZHIMIN</creatorcontrib><creatorcontrib>HUANG WEI</creatorcontrib><creatorcontrib>WANG JIALEI</creatorcontrib><creatorcontrib>HU XICHUN</creatorcontrib><creatorcontrib>LUO ZHIGUO</creatorcontrib><creatorcontrib>CAO JUNNING</creatorcontrib><title>Pan-cancer detection panel based on next-generation sequencing technology and application of detection panel</title><description>The invention belongs to the technical field of pan-cancer polygene detection and discloses a pan-cancer detection panel based on a next-generation sequencing technology. Important exon regions and partial intron regions of 141 genes are enriched by utilizing a gene probe hybridization method, so that accurate detection is achieved; and more importantly, a detection object is patient DNA, and ctDNA is combined with a gene panel to serve as an examination object, so that targeted detection can be realized, and the gene detection cost of a patient and the operation difficulty of an experimentercan be reduced. Meanwhile, a polygene screening list is made into a probe, and high-risk genes are detected in a targeted mode through hybridization capture sequencing, so that gene mutation with guiding significance for diagnosis and treatment can be detected more efficiently, and meanwhile certain tumor patients can be helped to participate in clinical trials. The pan-cancer detection panel hasimportant guiding signific</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>ENZYMOLOGY</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjbEOwjAQQ7swIOAfjg_IUDqgjKgqYkIM7NVxdUOl6BKaIMHfUwETE5Nl-dmeF_7EaoRVMFKHDMlDUIqs8HThhI4mq3hk46AY-R0n3O5QGdTR1Lhq8ME9ibUjjtEP8qFC_7u4LGY9-4TVVxfFet-c64NBDC1SZJk-clsfy7K0W1tt7K76h3kBSFBCOw</recordid><startdate>20201124</startdate><enddate>20201124</enddate><creator>ZHANG QUNLING</creator><creator>GUO WEIJIAN</creator><creator>TAO ZHONGHUA</creator><creator>ZHANG JIAN</creator><creator>SHI JINXIU</creator><creator>PEI YUCHEN</creator><creator>WU XIANGHUA</creator><creator>HU XIN</creator><creator>CHANG JIANHUA</creator><creator>ZHANG XIAOWEI</creator><creator>WANG YUNJIN</creator><creator>HU ZHIHUANG</creator><creator>SHAO ZHIMIN</creator><creator>HUANG WEI</creator><creator>WANG JIALEI</creator><creator>HU XICHUN</creator><creator>LUO ZHIGUO</creator><creator>CAO JUNNING</creator><scope>EVB</scope></search><sort><creationdate>20201124</creationdate><title>Pan-cancer detection panel based on next-generation sequencing technology and application of detection panel</title><author>ZHANG QUNLING ; GUO WEIJIAN ; TAO ZHONGHUA ; ZHANG JIAN ; SHI JINXIU ; PEI YUCHEN ; WU XIANGHUA ; HU XIN ; CHANG JIANHUA ; ZHANG XIAOWEI ; WANG YUNJIN ; HU ZHIHUANG ; SHAO ZHIMIN ; HUANG WEI ; WANG JIALEI ; HU XICHUN ; LUO ZHIGUO ; CAO JUNNING</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN111979329A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2020</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>ENZYMOLOGY</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>ZHANG QUNLING</creatorcontrib><creatorcontrib>GUO WEIJIAN</creatorcontrib><creatorcontrib>TAO ZHONGHUA</creatorcontrib><creatorcontrib>ZHANG JIAN</creatorcontrib><creatorcontrib>SHI JINXIU</creatorcontrib><creatorcontrib>PEI YUCHEN</creatorcontrib><creatorcontrib>WU XIANGHUA</creatorcontrib><creatorcontrib>HU XIN</creatorcontrib><creatorcontrib>CHANG JIANHUA</creatorcontrib><creatorcontrib>ZHANG XIAOWEI</creatorcontrib><creatorcontrib>WANG YUNJIN</creatorcontrib><creatorcontrib>HU ZHIHUANG</creatorcontrib><creatorcontrib>SHAO ZHIMIN</creatorcontrib><creatorcontrib>HUANG WEI</creatorcontrib><creatorcontrib>WANG JIALEI</creatorcontrib><creatorcontrib>HU XICHUN</creatorcontrib><creatorcontrib>LUO ZHIGUO</creatorcontrib><creatorcontrib>CAO JUNNING</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZHANG QUNLING</au><au>GUO WEIJIAN</au><au>TAO ZHONGHUA</au><au>ZHANG JIAN</au><au>SHI JINXIU</au><au>PEI YUCHEN</au><au>WU XIANGHUA</au><au>HU XIN</au><au>CHANG JIANHUA</au><au>ZHANG XIAOWEI</au><au>WANG YUNJIN</au><au>HU ZHIHUANG</au><au>SHAO ZHIMIN</au><au>HUANG WEI</au><au>WANG JIALEI</au><au>HU XICHUN</au><au>LUO ZHIGUO</au><au>CAO JUNNING</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Pan-cancer detection panel based on next-generation sequencing technology and application of detection panel</title><date>2020-11-24</date><risdate>2020</risdate><abstract>The invention belongs to the technical field of pan-cancer polygene detection and discloses a pan-cancer detection panel based on a next-generation sequencing technology. Important exon regions and partial intron regions of 141 genes are enriched by utilizing a gene probe hybridization method, so that accurate detection is achieved; and more importantly, a detection object is patient DNA, and ctDNA is combined with a gene panel to serve as an examination object, so that targeted detection can be realized, and the gene detection cost of a patient and the operation difficulty of an experimentercan be reduced. Meanwhile, a polygene screening list is made into a probe, and high-risk genes are detected in a targeted mode through hybridization capture sequencing, so that gene mutation with guiding significance for diagnosis and treatment can be detected more efficiently, and meanwhile certain tumor patients can be helped to participate in clinical trials. The pan-cancer detection panel hasimportant guiding signific</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN111979329A
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
VINEGAR
WINE
title Pan-cancer detection panel based on next-generation sequencing technology and application of detection panel
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T15%3A47%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZHANG%20QUNLING&rft.date=2020-11-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN111979329A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true